These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15720533)

  • 1. Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C.
    Markowitz JS; Gutterman EM; Hodes D; Klaskala W
    J Viral Hepat; 2005 Mar; 12(2):176-85. PubMed ID: 15720533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of characteristics of treated and non-treated patients with Hepatitis C infection.
    Hare CB; Morris JA; Chu A; Gotz V; Loveland JJ; Hodes D; Klaskala W
    Pharmacoepidemiol Drug Saf; 2006 Feb; 15(2):71-6. PubMed ID: 16136612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of illness of hepatitis C from a managed care organization perspective.
    Armstrong EP; Charland SL
    Curr Med Res Opin; 2004 May; 20(5):671-9. PubMed ID: 15140332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C among predialysis patients: prevalence and characteristics in a large cohort of patients.
    Lemos LB; Perez RM; Lemos MM; Draibe SA; Silva IS; Silva AE; Ferraz ML
    Nephron Clin Pract; 2008; 108(2):c135-40. PubMed ID: 18230916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necrolytic acral erythema in Egyptian patients with hepatitis C virus infection.
    El-Ghandour TM; Sakr MA; El-Sebai H; El-Gammal TF; El-Sayed MH
    J Gastroenterol Hepatol; 2006 Jul; 21(7):1200-6. PubMed ID: 16824076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta high-producer genotype is associated with response to hepatitis C virus-specific therapy in HIV-positive patients with acute hepatitis C.
    Nattermann J; Vogel M; Nischalke HD; Danta M; Ahlenstiel G; Michalk M; Sauerbruch T; Rockstroh JK; Spengler U;
    AIDS; 2008 Jul; 22(11):1287-92. PubMed ID: 18580607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of HCV infection in the general population: a survey in a southern Italian town.
    Cozzolongo R; Osella AR; Elba S; Petruzzi J; Buongiorno G; Giannuzzi V; Leone G; Bonfiglio C; Lanzilotta E; Manghisi OG; Leandro G; ; Donnaloia R; Fanelli V; Mirizzi F; Parziale L; Crupi G; Detomaso P; Labbate A; Zizzari S; Depalma M; Polignano A; Lopinto D; Daprile G
    Am J Gastroenterol; 2009 Nov; 104(11):2740-6. PubMed ID: 19638964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon alpha therapy for hepatitis C: treatment completion and response rates among patients with substance use disorders.
    Huckans MS; Loftis JM; Blackwell AD; Linke A; Hauser P
    Subst Abuse Treat Prev Policy; 2007 Jan; 2():4. PubMed ID: 17222348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
    Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
    Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of opioid abuse and misuse determined from a Medicaid database.
    McAdam-Marx C; Roland CL; Cleveland J; Oderda GM
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):5-18. PubMed ID: 20345194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttraumatic stress disorder and physical comorbidity among female children and adolescents: results from service-use data.
    Seng JS; Graham-Bermann SA; Clark MK; McCarthy AM; Ronis DL
    Pediatrics; 2005 Dec; 116(6):e767-76. PubMed ID: 16322133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
    Bini EJ; Bräu N; Currie S; Shen H; Anand BS; Hu KQ; Jeffers L; Ho SB; Johnson D; Schmidt WN; King P; Cheung R; Morgan TR; Awad J; Pedrosa M; Chang KM; Aytaman A; Simon F; Hagedorn C; Moseley R; Ahmad J; Mendenhall C; Waters B; Strader D; Sasaki AW; Rossi S; Wright TL
    Am J Gastroenterol; 2005 Aug; 100(8):1772-9. PubMed ID: 16086714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and epidemiology of hepatitis C virus in patients with squamous cell carcinoma of the head and neck.
    Nobles J; Wold C; Fazekas-May M; Gilbert J; Friedlander PL
    Laryngoscope; 2004 Dec; 114(12):2119-22. PubMed ID: 15564831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost effectiveness of alpha interferon in the treatment of chronic active hepatitis C.
    Shiell A; Briggs A; Farrell GC
    Med J Aust; 1994 Mar; 160(5):268-72. PubMed ID: 8107627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of risk factors and health outcomes among persons with asthma.
    Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
    J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.